Consistent with the proteomics results, c-Met was significantly upregulated in ccRCC samples that had high myoferlin expression compared to those with low myoferlin expression (Mann–Whitney test, p < 0.0001) (Figure 2a). This evidence concerns the gene MET and nonpapillary renal cell carcinoma.